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During mitosis, the entire content of the cell must be di-
vided equally between two daughter cells before karyo-
and cytokinesis are completed. How is this complex pro-
cess accomplished? In the case of the Golgi, it was found
many years ago in tissue culture cells that the characteris-
tic stack-like organization of the Golgi fragmented at the
onset of mitosis (Robbins and Gonatas, 1964; Lucocq and
Warren, 1987), and that Golgi fragments were subse-
quently distributed to each daughter cell. The identity of
these Golgi fragments and the mechanisms involved in
Golgi fragmentation and in the segregation of membranes
and Golgi contents to daughter cells are currently the sub-
ject of considerable study and debate.
In this issue of 
 
JCB
 
, three papers are published on Golgi
fragmentation during mitosis (Kano et al., 2000; Lowe et
al., 2000; Colanzi et al., 2000), which, together with papers
published recently in 
 
Cell
 
 (Zaal et al., 1999) and 
 
Molecular
Biology
 
 
 
of the Cell
 
 (Terasaki, 2000), provide new insights
into Golgi fragmentation, the mechanisms involved, and
the experimental difficulties in analyzing this process. The
background of these papers is also discussed, however, this
commentary
 
 
 
is not an exhaustive review of the literature
on Golgi inheritance during mitosis (see Warren and
Wickner, 1996). Nor is it a treatise on different models of
Golgi inheritance or the pros and cons for those models. It
is written from the perspective of an outsider, like most of
you reading this, who wants to understand from the
printed word and published data what happens to the
Golgi during mitosis.
We will consider two points. First, changes in Golgi or-
ganization during mitosis: we will discuss evidence for dif-
ferent stages in Golgi fragmentation, whether there is ret-
rograde membrane flow from the Golgi to the ER, and the
possible significance of the ER as an end-point in this pro-
cess. Second, mechanisms underlying these changes: we
will discuss the evidence for roles of MEK1 (mitogen-acti-
 
vated protein kinase kinase, MAPKK)
 
1
 
 and Cdc2, whether
these kinases work alone or sequentially in Golgi fragmen-
tation, and consider the evidence for specific targets of
these kinases that might mediate Golgi fragmentation.
 
Changes in Golgi Morphology during Mitosis: 
Stacks, Blobs, and ER
 
Stages in Golgi Fragmentation
 
In this issue of 
 
JCB
 
, Kano et al. (2000) describe changes in
Golgi organization during mitosis by examining MDCK
epithelial cells expressing the Golgi enzyme galactosyl-
transferase tagged with green fluorescent protein (GalT-
GFP). To induce mitotic-specific changes in the Golgi,
Kano et al. (2000) perforated the cell membrane with the
 
bacterial toxin streptolysin O, washed the cells with 1 M KCl
to remove cytosolic and peripheral membrane proteins,
and then added back cytosol from metaphase-arrested 
 
Xe-
nopus 
 
eggs and an ATP regenerating system. Confocal mi-
croscopy revealed a rapid change in Golgi morphology
from a perinuclear, reticular organization to a more frag-
mented structure composed of large blobs, the number of
which appears to diminish over time. During this time
there is also an increase in diffuse background fluores-
cence throughout the cell and the appearance of GalT-
GFP fluorescence in the nuclear envelope. This is shown
in Figure 3 B of Kano et al. (2000), in which a flat cell in
low density culture is examined. (Figures 1, 2, and 3 A of
Kano et al. [2000] examined confluent monolayers of cells
in which the height and narrowness of the cell compromise
the interpretation of the data, and laser damage from con-
tinuous confocal imaging over long periods was deleteri-
ous.) These fragmented Golgi structures are investigated
by electron microscopy (see Figure 4; immunoelectron mi-
croscopy was not performed to identify membranes), and
by immunofluorescence microscopy to compare the distri-
bution of GalT-GFP with that of an ER marker protein
(protein disulfide isomerase, PDI; see Figure 5 B). The im-
munofluorescence data show colocalization of GalT-GFP
and PDI in the nuclear envelope (mid-section) and periph-
eral membranes in the apical confocal section of the cell,
although larger GalT-GFP blobs in this section are clearly
not labeled with PDI. Kano et al. (2000) conclude that the
Golgi changes from a stack-like reticulum to a more frag-
mented organization, composed of large membranous
blobs that have a Golgi identity (based on the absence of
an ER marker) and a membrane with an ER identity,
which has a more diffuse distribution throughout the cyto-
plasm.
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Abbreviations used in this paper:
 
 ERK, extracellular signal-regulated
protein kinase; GalT-GFP, galactosyltransferase tagged with green fluo-
rescent protein; ManII-GFP, mannosidase II-GFP; MEK1, mitogen-acti-
vated protein kinase kinase, MAPKK; NRK, normal rat kidney; PDI, pro-
tein disulfide isomerase. 
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Is the ER an End-Point in Golgi Fragmentation?
 
The description by Kano et al. (2000) of changes in Golgi
organization induced by mitotic cytosol supports recent
observations by Zaal et al. (1999) and Terasaki (2000).
Zaal et al. (1999) examined GalT-GFP distribution in in-
tact HeLa, CHO, and PTK1 cells, rather than permeabi-
lized cells. They report that the steady-state ratio of GalT-
GFP between the Golgi and ER is 
 
z
 
70:30 (see Figure 1 of
Zaal et al., 1999). Furthermore, they suggest that this ratio
reflects a steady-state distribution of GalT-GFP due to cy-
cling of the protein between these membrane compart-
ments. This suggestion is supported by several indepen-
dent experiments in which GalT-GFP accumulates in the
ER when the Golgi is dispersed (nocodazole; see Figure
3), or when ER export but not retrograde Golgi to ER
transport is blocked (expression of a dominant-negative
Sar1p; see Figure 3), or when the ER pool of GalT-GFP is
removed by photobleaching (see Figure 2).
Zaal et al. (1999) analyzed the distribution of GalT-GFP
in cells entering mitosis. They observe several, apparently
sequential stages in Golgi reorganization, beginning with
the loss of the perinuclear reticular structure, the appear-
ance of numerous, small non-motile structures (similar
to those described by Kano et al., 2000), which grew
fainter and disappeared, and finally a diffuse fluores-
cence throughout the cytoplasm (see Figure 4 of Zaal et
al., 1999). Zaal et al. (1999) note that small, GalT-GFP
positive structures are observed occasionally, but the dif-
fuse staining pattern predominates (
 
.
 
98% of the fluores-
cent signal). Similar, diffuse distributions of other Golgi
marker proteins, including endogenous GM130 (see be-
low), were observed (see Figure 4 B). Immunoelectron mi-
croscopy of mannosidase II-GFP (ManII-GFP) and en-
dogenous GalT revealed that in mitotic cells these Golgi
resident proteins are present in tubuloreticular structures
coated with ribosomes (see Figure 5), indicating an ER lo-
cation. Zaal et al. (1999) examined the mobility of GalT-
GFP and lipids in interphase and mitotic cell peripheral
membranes (ER) using photobleaching. Results show that
both diffuse rapidly and neither have a substantial immo-
bile fraction, which the authors interpret as evidence that
GalT-GFP is in a continuous membrane system (e.g., ER)
rather than a population of vesicles (but see Jesch and Lin-
stedt, 1998 for evidence from subcellular fractionation
studies that in mitosis a portion of Golgi residents are in
vesicles).
Zaal et al. (1999) propose that reorganization of the
Golgi during mitosis reflects the reversion to a constitutive
pathway of membrane cycling between the Golgi and the
ER, in which the rate of retrograde cycling from the Golgi
to ER is greatly increased over the rate in interphase cells
(see also Terasaki, 2000). In this view, Golgi fragmenta-
tion induced by brefeldin A, nocodazole or okadaic acid
(see below) reflects the accumulation of Golgi membranes
and contents at one (intermediate) stage or another of a
constitutive cycle in which complete absorption of the
Golgi membranes into the ER is the extreme conclusion.
A counter argument is that these stages represent diver-
gent pathways that do not reflect the normal process of
Golgi fragmentation during mitosis (Lowe et al., 2000; see
below).
 
Are Golgi Blobs an Intermediate or an End-Point in 
Golgi Fragmentation?
 
Terasaki (2000) examined Golgi dynamics (marked with
KDELR
 
m
 
-GFP) in sea urchin embryos during successive
cleavages of blastomeres. He also observed the formation
of numerous Golgi blobs during the onset of mitosis, and
that the number of these blobs decreased rapidly during
mitosis, although a corresponding increase in (diffuse) cy-
toplasmic staining was not apparent, perhaps due to the
shape of the cells. Previous studies by Shima et al. (1998)
used a GFP chimera of 
 
N
 
-acetylglucosaminyl-transferase
(NAGFP) to examine Golgi morphology in mitosis in
HeLa and VERO cells, and found that the Golgi stack re-
organized into numerous bright blobs in the cytoplasm,
which decreased in size during mitosis. However, blobs
containing NAGFP are quite numerous in the cytoplasm
during metaphase, although it is clear from the images that
a diffuse background fluorescence signal also increases
during mitosis (see Figure 3 of Lowe et al., 2000). In their
most recent study in this issue of 
 
JCB
 
, Lowe et al. (2000)
show confocal images of GM130 staining in metaphase
normal rat kidney (NRK) and HeLa cells which reveal nu-
merous GM130-positive blobs (see Figure 2 D), whereas
Zaal et al. (1999) showed, with the same antibody, a uni-
form, diffuse distribution of GM130 with no blobs (see
Figure 4 B of Zaal et al., 1999). Lowe et al. (2000) quantify
the amount of the Golgi marker protein GM130 in these
Golgi fragments (blobs) in mitotic cells and report that af-
ter subtraction of background staining they find that
 
z
 
50% of GM130 is present in the blobs (see Table I of
Lowe et al., 2000; the location of the other 50% of GM130
staining is not defined). In contrast, Zaal et al. (1999)
reported that 2% of GalT-GFP is in blobs, and the re-
mainder is diffusely distributed in the cytoplasm (ER).
Whether this difference in distributions of GM130 and
other Golgi residents reflects the method of preparing
cells for immunofluorescence (Lowe et al., 2000 used
100% methanol to fix/permeabilize cells, whereas Zaal et
al., 1999 used 2% formaldehyde followed by antibody in
PBS containing 0.15% saponin) is unclear.
 
Implications of a Golgi–ER Connection for
Golgi Reassembly
 
The presence of GalT-GFP in the ER during mitosis may
reflect the accumulation of newly-synthesized protein.
Zaal et al. (1999) showed that in the presence of the pro-
tein synthesis inhibitor cycloheximide, GalT-GFP still ap-
peared in the ER in interphase cells presumably as a result
of retrograde transport from the Golgi (Figure 2 of Zaal
et al., 1999), but this experiment was not shown for mi-
totic cells. However, Farmaki et al. (1999), who also found
GalT in ER membranes (and Golgi blobs) in mitotic cells,
showed that cycloheximide significantly reduced the amount
of GalT in the ER of mitotic cells (Figure 9 of Farmaki et
al., 1999).
If (a portion of the) Golgi resident proteins localize to
the ER during mitosis, then reformation of the Golgi
could involve export of proteins and membrane from the
ER leading reassembly of the Golgi stack. A reasonable
test of this hypothesis is to use a dominant-negative mu-
tant of Sar1p (mSar1p) to block ER export of proteins at 
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the end of mitosis and examine the effects on Golgi reas-
sembly. Zaal et al. (1999) micro-injected mSar1p into an
asynchronous cell population, then fixed cells 4 h later and
looked for cells that had completed mitosis (decondensing
chromatin in irregularly shaped nuclei in adjacent cells).
The data in Figure 8 of Zaal et al. (1999) show two appar-
ent daughters cells in which GalT-GFP is diffusely distrib-
uted throughout the cytoplasm, although a few bright
blobs of fluorescence are apparent in one of the daughter
cells. Zaal et al. (1999) conclude that the Golgi did not re-
assemble because export of Golgi resident proteins form
the ER was inhibited. Shima et al. (1998) micro-injected
purified mSar1p into cells at the G2/M boundary in a pop-
ulation that had been synchronized at G1. Their results
show that NAGFP accumulates in blobs throughout the
cytoplasm during pro-metaphase and metaphase (Figure
2, a–d of Shima et al., 1998). Shima et al. (1998) conclude
that Golgi fragmentation does not involve dissolution of a
Golgi resident protein into the ER. Although these results
appear to be contradictory, it is clear that these experi-
ments assay a different end-point in Golgi reorganization.
Zaal et al. (1999) examined whether the Golgi reassembles
following mitosis when protein export from the ER is
blocked by mSar1p. In contrast, Shima et al. (1998) exam-
ined whether the Golgi undergoes initial fragmentation in
mitotic cells expressing mSar1p; cells were not examined
through to cytokinesis to determine whether Golgi stacks
reassemble in daughter cells expressing mSar1p.
 
Linking Golgi Stacks–Blobs–ER: A Compromise 
Pathway for Golgi Fragmentation
 
Is there a consensus description of changes in Golgi orga-
nization during mitosis? All of the studies cited above de-
scribe an initial change in Golgi morphology from a peri-
nuclear, reticular stack-like structure in interphase, to a
less organized structure of large blobs distributed through-
out the cytoplasm in early stages of mitosis. At this point,
there appears to be a divergence in opinion. At one ex-
treme, it seems that 
 
.
 
98% of these Golgi blobs disappear,
and Golgi resident proteins appear in tubulovesicular
membranes containing ER proteins and ribosomes. At the
other extreme, the size of Golgi blobs may diminish but
many of the blobs remain intact (comprising 
 
z
 
50% of a
Golgi resident). In between these extremes, some Golgi
resident proteins appear in a diffuse, cytoplasmic mem-
brane distribution with ER markers, whereas another pop-
ulation is localized to Golgi blobs. That there is some vari-
ance in Golgi reorganization during mitosis is perhaps not
surprising given that many cells can apparently accomplish
segregation of Golgi stacks between daughter cells with-
out the requirement for fragmentation (Stanley et al.,
1997). Its seems feasible, therefore, that under some con-
ditions (of reconstitution, see below) Golgi fragmentation
may be partial (blobs), and that under other conditions
it may result in complete dissolution of the Golgi into
the ER.
 
Mechanisms of Golgi Fragmentation
during Mitosis
 
From these descriptions of Golgi organization in mitosis
 
we now turn to the mechanisms underlying these changes.
Entry into mitosis is regulated by the activation of a num-
ber of kinases. Recent studies have reported that mitogen-
activated protein kinase kinase (MAPKK, referred to here
as MEK1) activity is required for G2/M transition, activa-
tion of Cdc2 and progression into mitosis (see Wright et
al., 1999). Cdc2 activity is required for chromosome con-
densation, breakdown of the nuclear envelope, and assem-
bly of the mitotic spindle (see Nigg, 1995). The roles of
both MEK1 and Cdc2 in Golgi fragmentation have been
examined.
 
Experimental Approaches
 
Two basic experimental approaches have been taken to
dissect mechanisms of Golgi fragmentation. One involves
methods similar to those employed by Kano et al. (2000),
in which cells are permeabilized gently with detergent
(e.g., digitonin), washed with 1M KCl to remove endoge-
nous cytosol and peripheral membrane proteins, and then
the cells are incubated in cytosol from mitotic (or inter-
phase) cells together with an ATP regenerating system.
Cytosol can be supplemented with purified proteins, inhib-
itors, etc., or depleted of proteins by affinity chromatog-
raphy. Cells can then be processed directly for immuno-
fluorescence or electron microscopy, or for biochemical
analysis of proteins. The second method involves the use
of Golgi-enriched membrane fractions from cells to which
mitotic or interphase cytosol is added as above. After incu-
bation, membranes are separated from cytosol by centrifu-
gation through a sucrose pad. Membranes can then be pro-
cessed for biochemical analysis of proteins. Experiments
described below will be generally referred to as using cells
or Golgi-enriched membranes, respectively, to describe
these two methods.
 
A Role for MEK1 in Golgi Fragmentation
 
Initial studies of MEK1 (Acharya et al., 1998; Lowe et al.,
1998) tested the effects of a specific inhibitor of MEK1,
PD 098059, on Golgi fragmentation in NRK cells. Acharya
et al. (1998) showed a concentration-dependent inhibition
by PD098059 of both MEK1 activity and Golgi fragmenta-
tion (Figure 5 of Acharya et al., 1998), and that immune-
depletion of MEK1 from mitotic cytosol reduced by 50%
the activity of mitotic cytosol to induce Golgi fragmenta-
tion in permeabilized NRK cells (Figure 6). Lowe et al.
(1998) showed an example of a nonpermeabilized mitotic
NRK cell from a synchronized population treated with
PD098059 in which the Golgi is clearly fragmented. Al-
though this appears to contradict the observations by
Acharya et al. (1998), other studies have shown that
PD098059 blocks cells at the G2 boundary (see Wright et
al., 1999); it is unclear, therefore, how cells in the study by
Lowe et al. (1998) entered mitosis in the presence of this
inhibitor. Using Golgi-enriched membranes, Lowe et al.
(1998) also reported that although addition of PD098059
inhibited MEK1 activity in a dose-dependent manner,
there was no effect on Golgi fragmentation, nor was there
an effect when MEK1 protein was immune-depleted from
mitotic extracts (Figure 6 of Lowe et al., 1998). Further-
more, addition of PD098059 to nonpermeabilized NRK
cells blocked phosphorylation of two known downstream 
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targets of MEK1, ERK1 (extracellular signal-regulated
protein kinase 1), and ERK2 (Figure 7). Acharya et al.
(1998) also examined whether ERK1 and ERK2 were in-
volved in MEK1-induced Golgi fragmentation in their as-
say by immune-depleting ERK2 from mitotic extracts
(Figure 7 of Acharya et al., 1998), and by adding inacti-
vated ERK2 to mitotic extract (Figure 8). Acharya et al.
(1998) reported that depletion of ERK2 had no effect on
the activity of mitotic extract to induce Golgi fragmenta-
tion, and that addition of an inactivated ERK2 caused a
dose-dependent inhibition of Golgi fragmentation; pre-
sumably, the excess ERK2 competed MEK1 binding/activ-
ity away from other substrates that induce Golgi fragmen-
tation. Acharya et al. (1998) conclude that MEK1 must be
targeting substrates other than ERK2, and possibly ERK1,
that are involved in Golgi fragmentation.
The conditions used to examine the effects of PD098059
were different in these experiments, which could explain
the different results: Acharya et al. (1998) used cells per-
meabilized with digitonin, washed with 1M KCL, and then
reconstituted with mitotic extract for 1 h; Lowe et al.
(1998) used Golgi-enriched membranes reconstituted with
mitotic extract for 30 min. A possible resolution of these
differences is that the Golgi-enriched membranes used by
Lowe et al. (1998) may have been stripped of the MEK1
target during isolation, and thereby Golgi fragmentation
would be refractory to the MEK1 inhibitor, PD098059;
presumably, the target(s) are not removed by the 1-M KCl
wash applied to permeabilized cells (Acharya et al., 1998).
 
Upstream and Downstream Components of a
MEK1 Pathway
 
In this issue of 
 
JCB
 
, Colanzi et al. (2000) extend the analy-
sis of MEK1 in Golgi fragmentation. They report that
MEK1 is hyperphosphorylated in mitotic extract, although
the site(s) of phosphorylation on MEK1 and the upstream
kinase(s) and downstream target(s) involved are as yet un-
known (see Figures 1 and 2 of Colanzi et al., 2000). Re-
moval of eight NH
 
2
 
-terminal amino acids by bacterial an-
thrax toxin is known to block MEK1 binding to ERK1
and ERK2. Cleavage of this domain of MEK1 did not in-
hibit hyperphosphorylation of MEK1 by mitotic extract,
or induction of Golgi fragmentation in NRK cells (see Fig-
ures 4 and 5). This confirms a previous result from Lowe et
al. (1998) who showed with Golgi-enriched membranes
that bacterial anthrax toxin inhibited ERK1 and ERK2
phosphorylation (by MEK1) and mitotic cytosol treated
with anthrax toxin induced Golgi fragmentation (Figure
7). Although Lowe et al. (1998) interpret this result to
mean that MEK1 is not involved in Golgi fragmentation,
Colanzi et al. (2000) conclude that phosphorylation of
MEK1 by an unknown kinase in mitotic extract promotes
MEK1 activity towards a substrate(s), other than ERK1/2,
that is involved in Golgi fragmentation (see also Acharya
et al., 1998, and above). A good test of mitotic activation
of MEK1 by an upstream kinase would be to use bacteri-
ally expressed, nonphosphorylated MEK1, which was
shown previously to rescue the Golgi fragmentation activ-
ity when added to MEK1-depleted mitotic extract (Ach-
arya et al., 1998), and determine whether it is specifically
hyperphosphorylated by mitotic extract. Clearly, identifi-
 
cation of putative MEK1 target(s) that are not ERK1 or
ERK2 will be critical in clearing up remaining ambiguities
in these experiments and results, and for elucidating mech-
anisms involved in Golgi fragmentation by MEK1.
 
A Role for Cdc2 in Golgi Fragmentation
 
Although MEK1 target(s) involved in Golgi fragmenta-
tion are yet to be uncovered, potential targets for Cdc2
have been examined in detail. Previous studies described a
series of protein-protein interactions in the Golgi involv-
ing a putative structural Golgi matrix protein GM130, that
binds to both a Golgi cisternal membrane-associated pro-
tein GRASP65, and to a vesicle protein p115, which in
turn binds to a Golgi vesicle membrane protein, giantin
(Nakamura et al., 1997). During Golgi fragmentation at
the onset of mitosis, these protein-protein interactions are
disrupted.
Lowe et al. (1998) examined whether any of these pro-
teins are a target of Cdc2 kinase activity. They showed that
GM130 on Golgi-enriched membranes is phosphorylated
upon addition of mitotic extract or purified Cdc2, and that
depletion of Cdc2 from mitotic extract significantly re-
duced GM130 phosphorylation (Figure 2 of Lowe et
al., 1998) and Golgi fragmentation (Figure 5). Whether
GM130 on Golgi membranes is directly phosphorylated by
Cdc2 kinase, or Cdc2 activates a downstream kinase that
phosphorylates GM130, or whether there are additional
targets of the Cdc2 kinase cascade that cause Golgi frag-
mentation is unclear. That GM130 may be a direct sub-
strate for Cdc2 is implicated by the presence of a putative
Cdc2 phosphorylation site on Ser25 (Figure 3), and that
NH
 
2
 
-terminal peptide of GM130 can be phosphorylated in
vitro by Cdc2 (Figure 2).
Seemingly complementary experiments were performed
by Acharya et al. (1998) in which Golgi fragmentation was
examined in permeabilized NRK cells incubated with mi-
totic extract that had been depleted of Cdc2, or with frac-
tions of mitotic extract that had been separated by phos-
phocellulose chromatography (Figure 3 of Acharya et al.,
1998). Acharya et al. (1998) report that Cdc2-depleted
mitotic extract induces Golgi fragmentation, and that frac-
tions enriched in Cdc2 from the phosphocellulose column
do not induce Golgi fragmentation. Although these data
appear to contradict the results of Lowe et al. (1998), it is
reasonable to speculate that the different sources of Golgi
may be responsible. Cdc2-independent Golgi fragmenta-
tion in permeabilized cells could be due to retention of
some endogenous Cdc2 activity (but see Figure 6 in Co-
lanzi et al., 2000), or the presence of another kinase(s) that
can be activated in a Cdc2-independent manner by other
factors in the mitotic extract. Cdc2-dependent Golgi frag-
mentation in isolated, Golgi-enriched membranes could
be due to the loss (due to the isolation procedure) of ki-
nases that could either substitute for Cdc2 or can be acti-
vated by other factors in mitotic extract. In both cases, one
of these kinases may be MEK1. Nevertheless, the data
from Lowe et al. (1998) show that GM130 is phosphory-
lated by mitotic extract and that Ser25 is a site for phos-
phorylation, both of which correlate with Golgi fragmen-
tation, and that Cdc2 is involved directly or indirectly in
this process. Whether MEK1 or Cdc2 is redundant in this 
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process, or acts sequentially will be discussed below when
we return to the Kano et al. (2000) paper.
 
A Role for GM130 Phosphorylation and 
Dephosphorylation in Golgi Organization
 
In this issue of 
 
JCB
 
, Lowe et al. (2000) continue the analy-
sis of the role of GM130 phosphorylation in Golgi frag-
mentation in mitosis. They raise an antibody (P25) to a
synthetic peptide comprising residues 21–31 of GM130
that includes phosphorylated serine25. Using this impor-
tant reagent, Lowe et al. (2000) examined the expression
and subcellular distribution of the mitotic-specific, phos-
phorylated form of GM130. As expected from their previ-
ous studies (see above), they find that P25 reacts with
GM130 only during mitosis (Figure 4 C of Lowe et al.,
2000) and stains predominantly large Golgi blobs through-
out the cytoplasm of those cells (Figures 2–4). Little or no
background staining is observed with P25, but the level of
GM130 in these Golgi blobs is reported to be 
 
z
 
50% of to-
tal GM130 staining in the cells (Table I). If the remainder
is background staining in the cytoplasm (ER?) then the
lack of P25 staining there may reflect the presence of de-
phosphorylated GM130. A test of this notion would be to
determine the percentage of total GM130 that is phos-
phorylated on ser25 during different stages of mitosis, and
the subcellular distribution of GM130 that is not phos-
phorylated on ser25.
One consequence of ser25 phosphorylation of GM130 is
that GM130 binds poorly to its partner p115 (see also
Lowe et al., 1998). Double immunofluorescence of mitotic
cells with P25 and p115 antibodies reveals some overlap in
staining patterns (Figure 4 A of Lowe et al., 2000), but
quantification of the apparent ratio of P25/p115 in Golgi
blobs shows a decrease from 1 in interphase cells to 
 
z
 
0.22
in mitotic cells (Lowe et al., 2000; Table II). In contrast,
Golgi fragmentation induced by ilimaquinone or nocoda-
zole results in Golgi blobs that do not react with P25, but
strongly costain with GM130 and p115 antibodies (Figure
5 C of Lowe et al., 2000). Again, two conclusions may be
drawn from these results. First, drug-induced Golgi frag-
mentation involves pathways different from those used for
Golgi fragmentation in mitosis that require GM130 phos-
phorylation and GM130/p115 dissociation. Second, Golgi
fragmentation does not require GM130 phosphorylation
and GM130/p115 dissociation per se, and that even in mi-
tosis alternate, or parallel pathways are available to induce
Golgi fragmentation (see below).
P25 staining of ser25 phosphorylated GM130 disappears
upon completion of mitosis (Figures 2 and 4 C), indicating
that GM130 becomes dephosphorylated. Therefore, Lowe
et al. (2000) investigated whether phosphatases are in-
volved in Golgi fragmentation, and in regulating the phos-
phorylation state of GM130. Addition of the protein phos-
phatase PP1 and PP2A inhibitor, okadaic acid, had little or
no effect on mitotic extract-induced Golgi fragmentation
in whole cells, but P25 staining was weak to absent and
GM130 and p115 colocalized strongly on Golgi blobs as
expected if GM130 is not phosphorylated on ser25 (Figure
5 A). Given the suggested role of cdc2 in Golgi fragmenta-
tion (see above), this result is somewhat surprising as oka-
daic acid has been reported previously to accelerate entry
into mitosis by eliciting the premature hyperphosphoryla-
tion of cdc25 which can then dephosphorylate and activate
cdc2 (Kumagai and Dunphy, 1992). However, Lowe et al.
(2000) got a more expected result by performing the same
experiment with Golgi-enriched membranes; in the pres-
ence of okadaic acid, GM130 was phosphorylated on ser25
(P25 reactive) and p115 was not associated with the mem-
branes (Figure 5 B). Lowe et al. (2000) go on to show that
addition of interphase cytosol results in loss of GM130
phosphorylation on ser25 in a dose-dependent and oka-
daic acid inhibited manner (Figure 6, A and B). The re-
sponsible phosphatase is shown to be PP2A, rather than
PP1 using specific inhibitors (Figure 6 C), purified protein
(Figure 7), and reconstituted PP2A complexes (Figure 8).
Although cell fractionation shows that PP2A is enriched in
membranes containing Golgi, it would be important to
show Golgi localization by immunofluorescence micros-
copy. It will also be interesting to understand mechanis-
tically how phosphorylation and dephosphorylation of
GM130 leads to changes in p115 binding and Golgi frag-
mentation.
 
Partner Mechanism: Do MEK1 and Cdc2
Work Sequentially?
 
Clearly, kinases and phosphatases are involved in many
aspects of Golgi fragmentation, and the question arises
whether different kinases, for example, are redundant or
act sequentially in facilitating Golgi inheritance during mi-
tosis. We now return to the paper by Kano et al. (2000)
published in this issue of 
 
JCB
 
. Recall that Kano et al.
(2000) provided evidence for Golgi fragmentation into
blobs, and partial dissolution of Golgi into ER (see
above). By staging the extent of Golgi fragmentation in
cells as intact (no fragmentation), punctate (blobs) or
dispersed (ER distribution), Kano et al. (2000) asked
whether inhibitors of MEK1 and Cdc2 act in a stage-spe-
cific manner to block Golgi fragmentation induced by mi-
totic extract (Figures 8–10 of Kano et al., 2000); unfortu-
nately, final concentrations of these inhibitors are not
given and assays of kinase inhibition are not shown. They
report that butyrolactone, an inhibitor of Cdc2, did not ef-
fect Golgi fragmentation into blobs (
 
.
 
80% of cells) but
inhibited the appearance of GalT-GFP in the ER (
 
,
 
10%
of cells, compared with 
 
.
 
65% of cells in the control); the
MEK1 inhibitor PD098059 increased to 40% the number
of cells unable to undergo Golgi fragmentation (similar to
that caused by the broad-range kinase inhibitor staurospo-
rine); and, a combination of butyrolactone and PD098059
inhibited all Golgi fragmentation in 
 
.
 
80% of cells (Figure
8). These general trends in the effects of inhibiting Cdc2
and MEK1 on Golgi fragmentation are complemented by
a separate series of experiments in which either kinase is
depleted from mitotic extract (Figure 9). These results
confirm roles of both MEK1 and Cdc2 in Golgi fragmenta-
tion. Finally, Kano et al. (2000) investigated whether acti-
vation of MEK1 with STE11, and/or activation of Cdc2
with cyclin A in interphase cytosol causes Golgi fragmen-
tation (Figure 10). Although MEK1 is active in interphase
cytosol, inhibition by PD098059 blocks all Golgi fragmen-
tation in 
 
.
 
75% of cells. STE11 activates MEK1 in inter-
phase cytosol and causes GalT-GFP dispersal into the ER 
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in 
 
.
 
60% of cells, whereas activation of Cdc2 with cyclin A
causes GalT-GFP accumulation equally in intact Golgi,
Golgi blobs, and the ER. Significantly, sequential activa-
tion of MEK1 and then Cdc2 causes essentially all of the
cells to disperse GalT-GFP into the ER, whereas sequen-
tial activation of Cdc2 and then MEK1 causes the equal
accumulation of GalT-GFP in Golgi blobs and the ER.
In conclusion, the results presented in papers published
in this issue of 
 
JCB
 
 and elsewhere have sought to in-
vestigate pathways of Golgi fragmentation, and roles of
MEK1 and Cdc2. The results and their interpretation are
sometimes controversial and/or ambiguous. Often, 2 ex-
periments that seem to address the same question have
different outcomes. Such discrepancies may be due to dif-
ferences in experimental approaches, in experimental end-
points, or in the weight given to results of different experi-
ments.
Mitotic Golgi fragmentation appears to be a linear set of
reactions that converts stacks to membranous blobs that
undergo further reorganization through tubulovesicula-
tion and become continuous with the ER membrane.
However, it should be noted that initiation, let alone com-
pletion of this reaction might not be required for partition-
ing of the Golgi into daughter cells, since many cells ac-
complish this process without Golgi fragmentation. MEK1
and Cdc2 may work sequentially to drive the reorganiza-
tion of the Golgi stack into blobs (MEK1 dependent), and
then from blobs into a more dispersed state throughout
the cytoplasm (Cdc2 dependent) which, in the extreme,
can lead to reabsorption of Golgi membranes into the ER.
Cdc2 may also have a role in initial Golgi fragmentation as
blobs are formed when only Cdc2 is activated, and inhibi-
tion of both MEK1 and Cdc2 inhibits Golgi fragmentation
to an extent greater than that when only one of them is in-
hibited. It is possible that these Cdc2-induced blobs are
different from those formed by MEK1 activation and
other events that induce Golgi fragmentation (e.g., no-
codazole, brefeldin A, okadaic acid, ilimaquinone), or,
more likely, represent another, perhaps later, intermediate
stage in Golgi fragmentation in the same linear pathway
that involves MEK1. Presumably, different assay condi-
tions (and different cells) have the capacity to drive Golgi
fragmentation to specific intermediates in this reaction,
and not necessarily to completion.
Clearly, the next steps are to define substrates for
MEK1 and Cdc2, and proteins associated with Golgi mem-
branes (besides GM130) that are the end-point targets of
these activators and/or their substrates. Other proteins im-
plicated in Golgi fragmentation, including coatamer (Mis-
teli and Warren, 1994), and protein G
 
bg
 
 and protein ki-
nase D (Jamora et al., 1999), may need to be incorporated
into these pathways. The goal remains to determine mech-
anistically how target proteins of these different activators
are involved in Golgi organization, Golgi fragmentation
during mitosis, and Golgi reassembly at the end of telo-
phase.
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